These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
OR
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Maryland
|
|
38-3888962
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
405 Park Ave., 15
th
Floor New York, NY
|
|
10022
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
(212) 415-6500
|
||
|
(Registrant's telephone number, including area code)
|
||
|
Large accelerated filer
o
|
|
Accelerated filer
o
|
|
Non-accelerated filer
x
|
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
|
(Unaudited)
|
|
|
||||
|
ASSETS
|
|
|
|
||||
|
Cash
|
$
|
3
|
|
|
$
|
3
|
|
|
Deferred costs
|
—
|
|
|
807
|
|
||
|
Total assets
|
$
|
3
|
|
|
$
|
810
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
|
|
|
||||
|
Accounts payable and accrued expenses
|
$
|
1,182
|
|
|
$
|
625
|
|
|
|
|
|
|
||||
|
Preferred stock, $0.01 par value, 50,000,000 authorized, none issued and outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par value, 300,000,000 shares authorized, 12,887 and 8,888 shares of common stock issued and outstanding as of March 31, 2013 and December 31, 2012, respectively
|
—
|
|
|
—
|
|
||
|
Additional paid-in capital
|
(1,117
|
)
|
|
200
|
|
||
|
Accumulated deficit during the development stage
|
(62
|
)
|
|
(15
|
)
|
||
|
Total stockholders' equity (deficit)
|
(1,179
|
)
|
|
185
|
|
||
|
Total liabilities and stockholders' equity (deficit)
|
$
|
3
|
|
|
$
|
810
|
|
|
|
|
Three Months Ended
|
|
Period from
October 15, 2012
(date of inception) to
|
||||
|
|
|
March 31, 2013
|
|
March 31, 2013
|
||||
|
|
|
|
|
|
||||
|
Revenues
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
||||
|
Expenses:
|
|
|
|
|
||||
|
General and administrative
|
|
47
|
|
|
62
|
|
||
|
Total expenses
|
|
47
|
|
|
62
|
|
||
|
Net loss
|
|
$
|
(47
|
)
|
|
$
|
(62
|
)
|
|
Comprehensive loss
|
|
$
|
(47
|
)
|
|
$
|
(62
|
)
|
|
|
Common Stock
|
|
|
|
Accumulated Deficit
During the Development Stage
|
|
|
|||||||||||
|
|
Number of
Shares
|
|
Par Value
|
|
Additional
Paid-in
Capital
|
|
|
Total Stockholders' Equity (Deficit)
|
||||||||||
|
Balance, October 15, 2012
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Issuance of common stock
|
8,888
|
|
|
—
|
|
|
200
|
|
|
—
|
|
|
200
|
|
||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(15
|
)
|
|
(15
|
)
|
||||
|
Balance, December 31, 2012
|
8,888
|
|
|
—
|
|
|
200
|
|
|
(15
|
)
|
|
185
|
|
||||
|
Common stock offering costs
|
—
|
|
|
—
|
|
|
(1,320
|
)
|
|
—
|
|
|
(1,320
|
)
|
||||
|
Share-based compensation
|
3,999
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
3
|
|
||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(47
|
)
|
|
(47
|
)
|
||||
|
Balance, March 31, 2013
|
12,887
|
|
|
$
|
—
|
|
|
$
|
(1,117
|
)
|
|
$
|
(62
|
)
|
|
$
|
(1,179
|
)
|
|
|
Three Months Ended
|
|
Period from
October 15, 2012
(date of inception) to
|
||||
|
|
March 31, 2013
|
|
March 31, 2013
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net loss
|
$
|
(47
|
)
|
|
$
|
(62
|
)
|
|
Adjustment to reconcile net loss to net cash used in operating activities:
|
|
|
|
||||
|
Share-based compensation
|
3
|
|
|
3
|
|
||
|
Changes in assets and liabilities:
|
|
|
|
||||
|
Accounts payable and accrued expenses
|
44
|
|
|
59
|
|
||
|
Net cash used in operating activities
|
—
|
|
|
—
|
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|||
|
Proceeds from issuance of common stock
|
—
|
|
|
200
|
|
||
|
Payments of offering costs
|
(37
|
)
|
|
(638
|
)
|
||
|
Advances from affiliate
|
37
|
|
|
441
|
|
||
|
Net cash provided by financing activities
|
—
|
|
|
3
|
|
||
|
Net change in cash
|
—
|
|
|
3
|
|
||
|
Cash, beginning of period
|
3
|
|
|
—
|
|
||
|
Cash, end of period
|
$
|
3
|
|
|
$
|
3
|
|
|
|
|
|
|
||||
|
Non-Cash Financing Activities:
|
|
|
|
||||
|
Reclassification of deferred offering costs
|
$
|
807
|
|
|
$
|
—
|
|
|
Source of Capital
(in thousands)
|
|
Inception to March 31, 2013
|
|
April 1, 2013 to April 30. 2013
|
|
Total
|
||||||
|
Common stock
|
|
$
|
200
|
|
|
$
|
2,139
|
|
|
$
|
2,339
|
|
|
•
|
We have a limited operating history and no established financing sources.
|
|
•
|
The amount of the distributions declared and paid may decrease or distributions may be eliminated at any time. Due to the risks involved in the ownership of real estate, there is no guarantee of any return on your investment, and you may lose all or a portion of your investment.
|
|
•
|
Our ongoing initial public offering ("IPO") is a “blind pool” offering because we currently only own one property and have not identified any other investments, you will not have the opportunity to evaluate the merits and/or demerits of such investments.
|
|
•
|
We focus on acquiring a diversified portfolio of healthcare-related assets located in the United States and are subject to risks inherent in concentrating investments in the healthcare industry.
|
|
•
|
The healthcare industry is heavily regulated, and new laws or regulations, changes to existing laws or regulations, loss of licensure or failure to obtain licensure could result in the inability of tenants to make lease payments to us.
|
|
•
|
We are depending on our Advisor to select investments and conduct our operations. Adverse changes in the financial condition of our Advisor or our relationship with our Advisor could adversely affect us.
|
|
•
|
No public market exists for our shares of common stock, nor may a public market ever exist and our shares are, and may continue to be, illiquid.
|
|
•
|
Market conditions and other factors could cause us to delay our liquidity event beyond the sixth anniversary of the termination of our IPO. We also cannot assure you that we will be able to achieve a liquidity event.
|
|
•
|
We established the offering price in our IPO on an arbitrary basis; as a result, the actual value of your investment may be substantially less than what you pay.
|
|
•
|
There are substantial conflicts among the interests of our investors, our interests and the interests of our Advisor, American Realty Capital VII, LLC (our "Sponsor") and Realty Capital Securities (our "Dealer Manager") and their respective affiliates, which could result in decisions that are not in the best interests of our stockholders.
|
|
•
|
Our Sponsor is the sponsor of other publicly offered investment programs which invest generally in real estate assets, but not primarily in our target assets, and one publicly offered investment program that invests in the same assets as our target assets, most of which have substantially more resources than we do.
|
|
•
|
Our investment objectives and strategies may be changed without stockholder consent.
|
|
•
|
We are obligated to pay substantial fees to our Advisor, which may result in our Advisor recommending riskier investments.
|
|
•
|
We are obligated to pay American Realty Capital Healthcare II Special Limited Partner, LLC (the "Special Limited Partner"), a subordinated distribution upon termination of the advisory agreement, which may be substantial and, as a result, may discourage us from terminating the Advisor.
|
|
•
|
We may incur substantial debt, which could hinder our ability to pay distributions to our stockholders or could decrease the value of your investment if income on, or the value of, the property securing the debt falls.
|
|
•
|
Our organizational documents permit us to pay distributions from any source, including proceeds from the IPO. Any of these distributions may reduce the amount of capital we ultimately invest in properties and other permitted investments and negatively impact the value of your investment, especially if a substantial portion of our distributions are paid from the IPO.
|
|
•
|
Our failure to qualify or remain qualified as a real estate investment trust ("REIT") for U.S. federal income tax purposes would result in higher taxes, may adversely affect our operations, would reduce the amount of income available for distribution and would limit our ability to make distributions to our stockholders.
|
|
•
|
Within six months following our acquisition of at least $2.0 billion in total portfolio assets, the offering price and repurchase price for our shares, including shares sold pursuant to our distribution reinvestment plan (the "DRIP"), will be based on the net asset value ("NAV"), which may not accurately reflect the value of our assets.
|
|
•
|
There are limitations on ownership and transferability of our shares.
|
|
|
|
Three Months Ended
|
||
|
(In thousands)
|
|
March 31, 2013
|
||
|
Selling commissions and dealer manager fees
|
|
$
|
—
|
|
|
Other offering costs
|
|
513
|
|
|
|
Total offering costs
|
|
$
|
513
|
|
|
|
AMERICAN REALTY CAPITAL HEALTHCARE TRUST II, INC.
|
|
|
|
By:
|
/s/ Thomas P. D'Arcy
|
|
|
|
Thomas P. D'Arcy
|
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|
|
By:
|
/s/ Brian S. Block
|
|
|
|
Brian S. Block
|
|
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer) |
|
Exhibit No.
|
|
Description
|
|
1.1 *
|
|
Amended and Restated Exclusive Dealer Manager Agreement, dated as of April 9, 2013, among the Company, American Realty Capital Healthcare II Advisors, LLC and Realty Capital Securities, LLC
|
|
3.1 *
|
|
Articles of Amendment and Restatement
|
|
4.1 *
|
|
Agreement of Limited Partnership of American Realty Capital Healthcare Trust II Operating Partnership, L.P., dated as of February 14, 2013
|
|
10.1 *
|
|
Amended and Restated Subscription Escrow Agreement, dated as of March 14, 2013, among Realty Capital Securities, LLC, the Company and UMB Bank, N.A.
|
|
10.2 *
|
|
Advisory Agreement, dated as of February 14, 2013, by and among the Company, American Realty Capital Healthcare Trust II Operating Partnership, L.P. and American Realty Capital Healthcare II Advisors, LLC
|
|
10.2.1 *
|
|
First Amendment to Advisory Agreement, dated as of March 11, 2013, by and among the Company, American Realty Capital Healthcare Trust II Operating Partnership, L.P. and American Realty Capital Healthcare II Advisors, LLC
|
|
10.3 *
|
|
Property Management and Leasing Agreement, dated as of February 14, 2013, by and among the Company, American Realty Capital Healthcare Trust II Operating Partnership, L.P. and American Realty Capital Healthcare II Properties, LLC
|
|
10.4 *
|
|
Employee and Director Incentive Restricted Share Plan of the Company
|
|
10.5 *
|
|
Valuation Services Agreement between the Company and Duff & Phelps, LLC, dated January 31, 2013
|
|
10.6 *
|
|
Form of Restricted Share Award Agreement Pursuant to the Employee and Director Incentive Restricted Share Plan of the Company
|
|
10.7 *
|
|
Investment Opportunity Allocation Agreement, dated as of April 9, 2013, by and among the Company and American Realty Capital Healthcare Trust, Inc.
|
|
10.8 *
|
|
Agreement for Purchase and Sale of Real Property, effective as of April 22, 2013, by and between AR Capital, LLC and TST Appleton South, LLC
|
|
14 *
|
|
Code of Ethics
|
|
21 *
|
|
List of Subsidiaries
|
|
31.1 *
|
|
Certification of the Principal Executive Officer of the Company pursuant to Securities Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2 *
|
|
Certification of the Principal Financial Officer of the Company pursuant to Securities Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32 *
|
|
Written statements of the Principal Executive Officer and Principal Financial Officer of the Company pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101 *
|
|
XBRL (eXtensible Business Reporting Language). The following materials from American Realty Capital Healthcare Trust II, Inc.'s Quarterly Report on Form 10-Q for the three months ended March 31, 2013, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations and Comprehensive Loss, (iii) the Consolidated Statement of Changes in Equity, (iv) the Consolidated Statements of Cash Flows and (v) the Notes to the Consolidated Financial Statements. As provided in Rule 406T of Regulation S-T, this information in furnished and not filed for purpose of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|